Last edition
News about "Belief Pharmaceuticals"
Belief Pharmaceuticals' Haemophilia B Gene Therapy Approved in Macau
Macau approves Belief Pharmaceuticals’ Popedacoq gene therapy for haemophilia B, marking regional expansion after China approval and advancing access to one-time treatment solutions.
Belief Pharmaceuticals | 23/03/2026 | By News Bureau
Belief Pharmaceuticals Group has announced that its gene therapy BM-H901 injection (generic name: Popedacoq injection) has received approval from the Macau Drug Administration for treating adult patients with moderate to severe haemophilia B (congenital factor IX deficiency).
Belief Pharmaceuticals | 22/03/2026 | By Darshana | 101
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy